IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production

Journal of Immunology

Volumn 164, Issue 7, 2000, Pages 3608-3615

  Liu, Zhanju ^a   Geboes, Karel ^a   Colpaert, Stefaan ^a   D'Haens, Geert R ^a   Rutgeerts, Paul ^a   Ceuppens, Jan L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15;

ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENTERITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0034176003     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.7.3608     Document Type: Article

References (41)

1. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, et al. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965.
2. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822.
3. Giri, J.G., S. Kumaai, M. Ahdieh, D. J. Friend D, A. Loomis, K. Shanebeck, R. DuBose, D. Cosman, L. S. Park, and D. M. Anderson. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14:3654.
4. Tagaya, Y., R. N. Bamford, A. P. DeFilippis, and T. A. Waldmann. 1996. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329.
5. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:2578.
6. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735.
7. Wilkinson, P. C., and F. Y. Liew. 1995. Chemoattraction of human blood T lymphocytes by interleukin-15. J. Exp. Med. 181:1255.
8. Jonuleit, H., K. Wiedemann, G. Müller, J. Degwert, U. Hoppe, J. Knop, and A. H. Enk. 1997. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role of IL-15 in attraction of T cells. J. Immunol. 158:2610.
9. Kanegane, H., and G. Tosato. 1996. Activation of naive and memory T cells by interleukin-15. Blood 88:230.
10. + T cells for IFN-γ but have differential effects on priming for IL-4. J. Immunol. 156:2413.
11. Oppenheimer-Marks, N., R. I. Brezinschek, M. Mohamadzadeh, R. Vita, and P. E. Lipsky. 1998. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo. J. Clin. Invest. 101:1261.
12. Bulfone-Paus, S., D. Ungureanu, T. Pohl, G. Lindner, R. Paus, R. Rückert, H. Krause, and U. Kunzendorf. 1997. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3:1124.
13. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395.
14. Armitage, R. J., B. M. Macduff, J. Eisenman, R. Paxton, and K. H. Grabstein. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:483.
15. McInnes, I. B., J. Al-Mughales, M. Field, B. P. Leung, F. Huang, R. Dixon, R. D. Sturrock, P. C. Wilkinson, and F. Y. Liew. 1996. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2:175.
16. McInnes, I. B., B. P. Leung, R. D. Sturrock, M. Field, and F. Y. Liew. 1997. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat. Med. 3:189.
17. Strehlau, J., M. Pavlakis, M. Lipman, M. Shapiro, L. Vasconcellos, W. Harmon, and T. B. Strom. 1997. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc. Natl. Acad. Sci. USA 94:695.
18. Ruchatz, H., B. P. Leung, X. Wei, I. B. McInnes, and F. W. Liew. 1998. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J. Immunol. 160:5654.
19. Li, X. C., P. Roy-Chaudhury, W. W. Hancock, R. Manfro, M. S. Zand, Y. Li, X. X. Zheng, P. W. Nickerson, J. Steiger, T. R. Malek, and T. B. Strom. 1998. IL-2 and IL-4 double knockout mice reject islet allografts: a role of novel T cell growth factors in allograft rejection. J. Immunol. 161:890.
20. Kim, Y. S., W. Maslinski, X. X. Zheng, A. C. Stevens, X. C. Li, G. H. Tesch, V. R. Kelley, and T. B. Strom. 1998. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fcγ2a protein blocks delayed-type hypersensitivity. J. Immunol. 160:5742.
21. Jullien, D., P. A. Sieling, K. Uyemura, N. D. Mar, T. H. Rea, and R. L. Modlin. 1997. IL-15, an immunomodulator of T cell responses in intracellular infection. J. Immunol. 158:800.
22. Agostini, C., L. Trentin, M. Facco, R. Sancetta, A. Cerutti, C. Tassinari, L. Cimarosto, F. Adami, A. Cipriani, R. Zambello, and G. Semenzato. 1996. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 157:910.
23. Kirman, I., and O. H. Nielsen. 1996. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 91:1789.
24. Sakai, T., K. Kusugami, H. Nishimura, T. Ando, T. Yamaguchi, M. Ohsuga, K. Ina, A. Enomoto, Y. Kimura, and Y. Yoshikai. 1998. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 114:1237.
25. Liu, Z., S. Colpaert, G. R. D'Haens, A. Kasran, M. de Boer, P. Rutgeerts, K. Geboes, and J. L. Ceuppens. 1999. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J. Immunol. 163:4049.
26. Armant, M., R. Armitage, N. Boiani, G. Delespesse, and M. Sarfati. 1996. Functional CD40 ligand expression on T lymphocytes in the absence of T cell receptor engagement: involvement in interleukin-2-induced induced interleukin-12 and interferon-γ production. Eur. J. Immunol. 26:1430.
27. Zanussi, S., M. D'Andrea, C. Simonelli, D. Trabattoni, M. T. Bortolin, L. Caggiari, U. Tirelli, M. Clerici, and P. De Paoli. 1999. The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients. Scand. J. Immunol. 49:286.
28. Mori, A., M. Suko, O. Kaminuma, S. Inoue, T. Ohraura, Y. Nishizaki, T. Nagahori, Y. Asakura, A. Hoshino, Y. Okumura, et al. 1996. IL-15 promotes cytokine production of human T helper cells. J. Immunol. 156:2400.
29. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182.
30. Papadakis, K. A., and S. R. Targan. 1999. Current theories on the causes of inflammatory bowel disease. Gastroenterol. Clin. North Am. 28:283.
31. + T cells in the absence of TCR ligation. J. Immunol. 161:3408.
32. Tesli, R., D. D'Ambrosio, R. De Maria, and A. Santoni. 1994. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15:479.
33. Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
34. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111.
35. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lamavecchia, and M. Colonna. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type 1 interferon. Nat. Med. 5:919.
36. Johnston, J. A., C. M Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan, K. Shibuya, J. R. Ortaldo, S. Gupta, Y. Q. Chen, J. D. Giri, and J. J. O'Shea. 1995 Tyrosine phosphorylation and activation of STATS, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acatl. Sci. USA 92:8705.
37. Schieferdecker, H. L., R. Ullrich, H. Hirseland, and M. Zeitz. 1992. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J. Immunol. 149:2816.
38. Targan, S. R., S. B. Hanauer, S. J. H. van Deventer, L. Mayer, D. H. Present, T. Braakman, K. L. DeWoody, T. F. Schaible, and P. J. Rutgeerts. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease. M. Engl. J. Med. 337:1029.
39. Kasyapa, C. S., C. L. Stentz, M. P. Davey, and D. W. Carr. 1999. Regulation of IL-15-stimulaled TNF-α production by rolipram. J. Immunol. 163:2836.
40. Monteleone, G., T. Parrello, F. Luzza, and F. Pallone. 1998. Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7. Gut 43:620.
41. Ebert, E. C. 1998. Interleukin-15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology 114:1439.